Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1878 1
1947 1
1950 1
1952 1
1954 1
1955 1
1957 1
1958 1
1961 2
1962 2
1963 1
1964 1
1965 2
1966 3
1967 5
1968 5
1969 2
1970 10
1971 10
1972 6
1973 6
1974 6
1975 9
1976 8
1977 9
1978 4
1979 12
1980 6
1981 11
1982 10
1983 13
1984 7
1985 5
1986 6
1987 12
1988 15
1989 11
1990 7
1991 11
1992 10
1993 21
1994 21
1995 25
1996 26
1997 28
1998 23
1999 20
2000 33
2001 33
2002 23
2003 37
2004 30
2005 16
2006 31
2007 30
2008 35
2009 35
2010 23
2011 37
2012 49
2013 63
2014 54
2015 65
2016 72
2017 89
2018 129
2019 152
2020 172
2021 184
2022 142
2023 108
2024 99
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,882 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous mastocytosis: A dermatological perspective.
Di Raimondo C, Del Duca E, Silvaggio D, Di Prete M, Lombardo P, Mazzeo M, Spallone G, Campione E, Botti E, Bianchi L. Di Raimondo C, et al. Among authors: bianchi l. Australas J Dermatol. 2021 Feb;62(1):e1-e7. doi: 10.1111/ajd.13443. Epub 2020 Oct 11. Australas J Dermatol. 2021. PMID: 33040350 Review.
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Marzano AV, et al. Among authors: bianchi l. Br J Dermatol. 2021 Jan;184(1):133-140. doi: 10.1111/bjd.18983. Epub 2020 Apr 13. Br J Dermatol. 2021. PMID: 32119111 Free article.
Effects of Combined Endurance and Resistance Eccentric Training on Muscle Function and Functional Performance in Patients With Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial.
Pancera S, Lopomo NF, Porta R, Sanniti A, Buraschi R, Bianchi LNC. Pancera S, et al. Among authors: bianchi lnc. Arch Phys Med Rehabil. 2024 Mar;105(3):470-479. doi: 10.1016/j.apmr.2023.09.004. Epub 2023 Sep 15. Arch Phys Med Rehabil. 2024. PMID: 37716519 Clinical Trial.
Apremilast for the treatment of psoriasis.
Chimenti MS, Gramiccia T, Saraceno R, Bianchi L, Garofalo V, Buonomo O, Perricone R, Chimenti S, Chiricozzi A. Chimenti MS, et al. Among authors: bianchi l. Expert Opin Pharmacother. 2015;16(13):2083-94. doi: 10.1517/14656566.2015.1076794. Epub 2015 Aug 4. Expert Opin Pharmacother. 2015. PMID: 26243735 Review.
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.
Chiricozzi A, Ferrucci SM, Di Nardo L, Gori N, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Caldarola G, De Simone C, Ippoliti E, Torres T, Gkalpakiotis S, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Peris K; MEDaCoTRA Study Group. Chiricozzi A, et al. Among authors: bianchi l. Expert Opin Biol Ther. 2023 Jul-Dec;23(12):1307-1315. doi: 10.1080/14712598.2023.2292627. Epub 2023 Dec 28. Expert Opin Biol Ther. 2023. PMID: 38108300
Erlotinib-induced bullous pemphigoid.
Stingeni L, Bianchi L, Minotti V, Lisi P. Stingeni L, et al. Among authors: bianchi l. J Am Acad Dermatol. 2012 Nov;67(5):e199-201. doi: 10.1016/j.jaad.2012.01.034. J Am Acad Dermatol. 2012. PMID: 23062911 No abstract available.
Tofacitinib for the treatment of moderate-to-severe psoriasis.
Chiricozzi A, Faleri S, Saraceno R, Bianchi L, Buonomo O, Chimenti S, Chimenti MS. Chiricozzi A, et al. Among authors: bianchi l. Expert Rev Clin Immunol. 2015 Apr;11(4):443-55. doi: 10.1586/1744666X.2015.1013534. Epub 2015 Feb 10. Expert Rev Clin Immunol. 2015. PMID: 25666451 Review.
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study.
Graceffa D, Zangrilli A, Caldarola G, Lora V, Orsini D, Moretta G, Pagnanelli G, Provini A, Masini C, Bavetta M, Giordano D, Richetta A, Tolino E, Bianchi L, Peris K, Sperati F, Bonifati C. Graceffa D, et al. Among authors: bianchi l. Int J Dermatol. 2024 Oct;63(10):1383-1391. doi: 10.1111/ijd.17156. Epub 2024 Apr 7. Int J Dermatol. 2024. PMID: 38584311
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis).
Gargiulo L, Narcisi A, Ibba L, Balato A, Bianchi L, Brianti P, Buononato D, Burlando M, Caldarola G, Campanati A, Campione E, Carrera CG, Carugno A, Cristaudo A, Cusano F, Dapavo P, Dattola A, De Simone C, Gaiani FM, Gisondi P, Giunta A, Loconsole F, Maione V, Mortato E, Marzano AV, Maurelli M, Megna M, Mercuri SR, Offidani A, Orsini D, Parodi A, Pellacani G, Potestio L, Quaglino P, Richetta AG, Romano F, Sena P, Venturini M, Malagoli P, Costanzo A. Gargiulo L, et al. Among authors: bianchi l. Front Med (Lausanne). 2023 Aug 8;10:1243843. doi: 10.3389/fmed.2023.1243843. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614958 Free PMC article.
1,882 results